So Marc; counsel for the Monitor aka PwC; choose to list Bioamber under restructuring when he simply could have moved it a few spaces down into his experiences in liquidations...yeah that explains the interest in our shares!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.